Department of Pathology and Transfusion Medicine, Sri Sathya Sai Institute of Higher Medical Sciences, Bangalore, EPIP Area, Whitefield 560066, India.
J Clin Neurosci. 2010 Dec;17(12):1597-9. doi: 10.1016/j.jocn.2010.03.053.
We report an unusual patient with a primary malignant ganglioglioma, World Health Organization (WHO) grade III, of the spinal cord at the D11-L1 level in an 11-year-old boy. The patient presented with low backache and progressive paraparesis. A MRI scan revealed a well-defined conus lesion extending from D11 to L1, which was predominantly isointense on T1- and T2-weighted images and enhanced with contrast. On histopathological evaluation, the tumor was found to be comprised of two different components. One of the components revealed typical ganglioglioma with dysmorphic ganglion cells, positive for synaptophysin on immunohistochemistry. The other component was cellular with a high mitotic activity, giant tumor cells and glial fibrillary acidic protein (GFAP) positivity. The MIB-1 labeling index was ≥ 75% in the latter component. We emphasize the role of the MIB-1 labeling index to predict the prognosis and further management in these rare occurrences.
我们报告了一例罕见的脊髓原发性恶性神经节胶质瘤病例,患者为 11 岁男孩,病变位于 D11-L1 水平,世界卫生组织(WHO)分级为 III 级。该患者以腰痛和进行性截瘫为主要表现。磁共振成像(MRI)扫描显示一个界限清楚的圆锥病变,从 D11 延伸至 L1,T1 加权像和 T2 加权像呈等信号,增强后强化。组织病理学评估发现,肿瘤由两种不同的成分组成。一种成分显示典型的神经节胶质瘤,有形态异常的神经节细胞,免疫组织化学显示突触素阳性。另一种成分为细胞性,有较高的有丝分裂活性、巨细胞瘤和胶质纤维酸性蛋白(GFAP)阳性。后者的 MIB-1 标记指数≥75%。我们强调 MIB-1 标记指数在预测这些罕见情况下的预后和进一步治疗中的作用。